Multiple sclerosis: New stem cell transplantation may ‘freeze’ disease progression – Telegraph.co.uk
Medical News Today |
Multiple sclerosis: New stem cell transplantation may ‘freeze’ disease progression
Telegraph.co.uk A multiple sclerosis treatment which “resets” the immune system has been found to “freeze” progression of the disease in nearly half of patients, according to scientists. A study led by Imperial College London found that 46% of patients who underwent … Multiple sclerosis: Stem cell transplantation may halt disease progressionMedical News Today New study examines long-term outcomes for MS patients after stem cell transplantationNews-Medical.net Stem cell transplants may help some with multiple sclerosisUPI.com The Times (subscription) –Daily Mail –Multiple Sclerosis News Today all 18 news articles » |
|
New Immunotherapy Candidate receives FDA Fast Track Designation
Labiotech.eu (blog) Cell Medica’s Orphan Drug CMD-003 has received fast track designation by the FDA to advance immunotherapy of patients with Epstein Bar Virus (EBV)-associated malignancies. The FDA’s fast track designation has been designed to facilitate and accelerate … Cell Medica: Lead Cancer Immunotherapy Candidate Receives FDA …Business Wire (press release) |
Forbes |
How Much Is a CRISPR Patent License Worth?
Forbes Last Wednesday, the Patent Trial and Appeal Board (PTAB) ruled in favor of the Broad Institute in the most monumental biotech patent dispute in decades: a patent “interference” trial over foundational patents covering CRISPR-Cas9, a revolutionary … |